Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers

British Journal of Cancer

Volumn 111, Issue 11, 2014, Pages 2076-2081

  Gill, M D ^a,b,c   Bramble, M G ^b,c   Hull, M A ^d   Mills, S J ^a,c   Morris, E ^d   Bradburn, D M ^a,c   Bury, Y ^e   Parker, C E ^c,f   Lee, T J W ^c,g   Rees, C J ^b,c,f  

^a Northern Colorectal Cancer Audit Group   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

^c Northern Region Endoscopy Group   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e ROYAL VICTORIA INFIRMARY   (United Kingdom)

^f CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

^g NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

Author keywords

cancer diagnosis; colorectal cancer; large intestine; screening

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; COMORBIDITY; ENDOSCOPIC POLYPECTOMY; INTESTINE CANCER; OCCULT BLOOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCREENING TEST; SURVIVAL RATE; AGED; CANCER STAGING; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS;

EID: 84927175056     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.498     Document Type: Article

References (24)

1. Amri R, Bordeianou LG, Sylla P, Berger DL (2013) Impact of screening colonoscopy on outcomes in colon cancer surgery. JAMA Surg 148(8): 747-754.
2. Arain MA, Sawhney M, Sheikh S, Anway R, Thyagarajan B, Bond JH, Shaukat A (2010) CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 105(5): 1189-1195.
3. Aravani A, Thomas J, Day M, Forman D, Morris E, Tatarek-Gintowt R (2009) Survival by Stage of Colorectal Cancer in England: Northern and Yorkshire Cancer Registry and Information Service.
4. Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H. (2010) Comparison of 17,641 patients with right-and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 53(1): 57-64. doi:10.1007/DCR.0b013e3181c703a4.
5. Cancer Research UK (2010) Bowel (colorectal) cancer-UK incidence statistics.
6. Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM (2012) Prevalence and predictors of interval colorectal cancers in Medicare beneficiaries. Cancer 118(12): 3044-3052.
7. Foutch P, Manne R, Sanowski R, Gaines J (1988) risk factors for blood loss from adenomatous polyps of the large bowel: a colonoscopic evaluation with histological correlation. J Clin Gastroenterol 10(1): 50-56.
8. Gill MD, Bramble MG, Rees CJ, Lee TJW, Bradburn DM, Mills SJ (2012) Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme. Br J Cancer 107(3): 417-421.
9. Harvey NT, Ruszkiewicz A (2007) Serrated neoplasia of the colorectum. World J Gastroenterol 13(28): 3792-3798.
10. Hirano K, Uno Y, Munakata A, Yoshida Y (1996) Factors that influence bleeding in superficial-type colorectal tumours: study of endoscopic and histological correlates. J Gastroenterol 31: 518-524.
11. Macrae FA, John DJS (1982) Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 82(5): 891-898.
12. Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N (2008) is there a difference in survival between right-versus left-sided colon cancers? Ann Surg Oncol 15(9): 2388-2394.
13. Mitchard JR, Love SB, Baxter KJ, Shepherd NA (2010) How important is peritoneal involvement in rectal cancer? A prospective study of 331 cases. Histopathology 57: 671-679.
14. Morris EJA, Whitehouse LE, Farrell T, Nickerson C, Thomas JD, Quirke P, Rutter MD, Rees C, Finan PJ, Wilkinson JR, Patnick J (2012a) A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer 107: 757-764.
15. Morris EJA, Whitehouse LE, Farrell T, Nickerson C, Thomas JD, Quirke P, Rutter MD, Rees C, Finan PJ, Wilkinson JR, Patnick J (2012b) A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer 107(5): 757-764.
16. NHS Cancer Screening Programmes (2006) Guide Book for Programme Hubs and Screening Centres: NHS Bowel Cancer Screening Programme.
17. Rajasekhar PT, Ritchie M, Rutter MD, Clifford G, Waddup G, Dempsey N, Rubin GP, Rees CJ (2012) Lower gastrointestinal symptoms are prevalent among individuals colonoscoped within the Bowel Cancer Screening Programme. Colorectal Dis 14(9): e603-e607.
18. Sawhney M, Farrar W, Gudiseva S, Nelson D, Lederle F, Rector T, Bond J (2006) Microsatellite instability in interval colon cancers. Gastroenterology 131(6): 1700-1705.
19. Shaukat A, Arain M, Thaygarajan B, Bond JH, Sawhney M (2010) Is BRAF mutation associated with interval colorectal cancers? Dig Dis Sci 55(8): 2352-2356.
20. Shepherd NA, Baxter KJ, Love SB (1997) The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112: 1096-1102.
21. Steele RJC, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser CG (2011) Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 61: 576-581.
22. Thomas WM, Pye G, Hardcastle JD, Chamberlain J, Charnley RM (1989) Role of dietary restriction in Haemoccult screening for colorectal cancer. Br J Surg 76(9): 976-978.
23. Uno Y, Munakata A (1995) Endoscopic and histologic correlates of colorectal polyp bleeding. Gastrointest Endosc 41(5): 460-467.
24. Weiss JM, Pfau PR, O'Connor ES, King J, LoConte N, Kennedy G, Smith MA (2011) Mortality by stage for right-versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-Medicare Data. J Clin Oncol 29(33): 4401-4409.